Integrative Chiropractic Techniques to Reduce Insulin Resistance

Discover how integrative chiropractic can reduce insulin resistance, improve wellness, and balance your body’s insulin levels.

Abstract

In this clinical exposition, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, present an evidence-informed investigation into how insulin resistance operates far beyond a simple metabolic or “fat storage” issue. Emerging clinical models confirm that insulin resistance represents a systemic pathophysiological state directly driving musculoskeletal deterioration, chronic pain, and aberrant tissue remodeling—such as benign adipose sequestering (lipomas) and accelerated joint degeneration. By synthesizing modern research in neuroendocrinology, metabolism, and connective tissue biology with clinical insights from our practice at Injury Medical Clinic PA in El Paso, Texas, we detail how insulin resistance impairs cellular autophagy, fuels systemic inflammation via advanced glycation end-products (AGEs) and lipopolysaccharides (LPS), disrupts the autonomic nervous system, and stiffens tendons and fascia. Furthermore, we demonstrate how conservative, non-surgical approaches—integrating evidence-based chiropractic adjustments, medical oversight led by our Medical Director Dr. Maria Guadalupe Cardenas, MD, targeted physical therapy, medical massage therapy, and functional wellness—interrupt the vicious cycle of pain, physical immobility, and metabolic failure.

About Our Team and Collaborative Model of Care

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our clinical philosophy addresses root-cause drivers rather than merely masking symptoms:

• Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST: My practice blends dual training in primary care nursing and chiropractic sciences with functional medicine, pain neuroscience, and neuromuscular rehabilitation.
• Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933): With over 40 years of medical experience, Dr. Cardenas oversees differential diagnoses, advanced laboratory panels, imaging, pharmacotherapy when warranted, and collaborative medical referrals.
• Multidisciplinary Treatment Synergy: The union of internal medicine and conservative musculoskeletal care allows us to address the metabolic, biochemical, structural, and neurological components of systemic disorders simultaneously.

Clinical perspectives, rehabilitative paradigms, and patient resources can be accessed at:

• Health Coach Clinic
• Dr. Alexander Jimenez on LinkedIn

How Insulin Resistance Impacts the Body and Musculoskeletal System

Insulin resistance occurs when target tissues—principally skeletal muscle, the liver, and adipose depots—exhibit a blunted biological response to normal circulating levels of insulin (Petersen & Shulman, 2018). While classically framed through the lens of type 2 diabetes and cardiovascular disease, insulin resistance exerts widespread destructive effects throughout the neuromusculoskeletal matrix.

• Chronic Hyperinsulinemia / IR leads to Connective Tissue Pathology, causing:
  • Microvascular ischemia
  • AGE collagen cross-linking
  • Tendon/fascia stiffness
  • Metabolic / Autophagy
  • Impaired GLUT4 in muscle
  • mTORC1 overactivation
  • Blocked autophagic flux
• This causes Neuromusculoskeletal Pain, Neuropathy & Immobility Cycles

1. Impaired Muscle Perfusion and Microvascular Ischemia

Insulin acts as a physiological vasodilator by stimulating endothelial nitric oxide synthase (eNOS) in capillary beds. In insulin-resistant states, pathway-specific impairment blocks nitric oxide production while leaving vasoconstrictive endothelin-1 pathways unchecked (Muniyappa et al., 2007).

• Skeletal muscle capillary recruitment decreases by up to 40–50%.
• Tissues suffer chronic low-grade hypoxia and nutrient starvation, triggering trigger points, localized ischemia, and myofascial tension.

2. Accumulation of Advanced Glycation End-Products (AGEs)

Persistent hyperinsulinemia and intermittent glycemic spikes drive non-enzymatic glycation of long-lived structural proteins (Brownlee, 2005).

• Collagen fibers within tendons, ligaments, and intervertebral discs develop pathological covalent cross-links.
• Tendons lose viscoelastic gliding, become brittle, and lose load compliance, predisposing patients to spontaneous tendinopathies, adhesive capsulitis (“frozen shoulder”), and spinal disc degeneration (de Oliveira et al., 2020).

3. Hyperinsulinemia, mTOR, and Autophagic Failure

Autophagy is the lysosomal degradation pathway essential for turning over damaged cellular organelles, misfolded proteins, and dysfunctional mitochondria (Levine & Kroemer, 2019). Sustained hyperinsulinemia hyperactivates mammalian target of rapamycin complex 1 (mTORC1), locking the cellular autophagy switch in the “off” position (Laplante & Sabatini, 2012).

• Cellular waste cannot be cleared and is instead compartmentalized into inflamed niches, dysfunctional fibrotic tissue, or benign growths such as lipomas.
• Mesenchymal stem cells exhibit premature senescence and secrete a pro-inflammatory senescence-associated secretory phenotype (SASP), perpetuating tissue pain (Childs et al., 2015).

The Cross-Talk: Insulin Resistance, Chronic Pain, and Comorbidities

Metabolic dysfunction and chronic pain do not merely coexist; they actively drive each other in a bidirectional biological feedback loop.

The Pain–Immobility–Metabolism Vicious Cycle

1. Insulin Resistance Causes Connective Tissue Stiffening: Diabetic cheiroarthropathy, diffuse idiopathic skeletal hyperostosis (DISH), rotator cuff tears, plantar fasciitis, and lumbar spinal canal stenosis show markedly higher incidence in individuals with insulin resistance (Erekat, 2022).
2. Structural Pain Discourages Physical Activity: When weight-bearing joints ache, patients walk less and cease resistance training.
3. Loss of Non-Insulin-Dependent Glucose Uptake: Muscle contractions normally stimulate glucose transporter type 4 (GLUT4) translocation directly, independently of insulin (Richter & Hargreaves, 2013). When musculoskeletal pain prevents movement, skeletal muscle loses its capacity as the primary glucose reservoir, worsening hyperinsulinemia and systemic inflammation.
4. Metabolic Exacerbation of Joint Stress: Elevated adipokines (leptin, resistin) and cytokines (TNF-?, IL-6) exacerbate cartilage destruction in osteoarthritis, establishing that joint degeneration in metabolic syndrome is not just “wear and tear,” but an active inflammatory osteochondral degradation (Berenbaum et al., 2017).

Musculoskeletal Condition	Insulin Resistance Correlation	Clinical Manifestation
Adhesive Capsulitis	Over 5-fold higher risk in dysglycemic states	Severe fibroblastic proliferation and capsular contraction
Rotator Cuff / Achilles Tendinopathy	Collagen cross-linking by AGEs, reduced vascularization	Micro-tears, failed tendon healing, early calcification
Osteoarthritis	Low-grade systemic inflammation and adipokine secretion	Accelerated chondrocyte apoptosis, synovial inflammation
Peripheral Neuropathy / Radiculopathy	Sorbitol accumulation, endoneurial ischemia	Burning neuropathic pain, allodynia, muscle atrophy
Lumbar Facet & Myofascial Pain	Paraspinal fatty infiltration and sympathetic tone	Morning stiffness, loss of thoracic extension, postural fatigue

Associated Comorbidities

Patients presenting with chronic spinal pain alongside insulin resistance frequently display:

• Cardiovascular Disease and Endothelial Dysfunction
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD/NAFLD)
• Metabolic Endotoxemia: Gut barrier hyperpermeability allowing lipopolysaccharide (LPS) leakage, which binds TLR4 receptors on spinal microglia and promotes central pain sensitization (Cani et al., 2007).
• Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysregulation: Chronic pain acts as an internal neurochemical stressor, keeping cortisol and catecholamines perpetually elevated, which worsens gluconeogenesis and blunts peripheral insulin sensitivity (Chrousos, 2009).

Discovering the Benefits of Chiropractic Care- Video

How Chiropractic Care Directly Intervenes in Insulin Resistance

A common misconception is that chiropractic interventions only treat isolated spinal mechanics. In reality, biomechanics and metabolic health are coupled through the neuroendocrine and autonomic systems.

1. Neuromechanical Balancing of the Autonomic Nervous System

Spinal joint fixation and subluxation generate continuous aberrant nociceptive barrages that stimulate the sympathetic chain within the intermediolateral cell column of the spinal cord (Pickar, 2002). Persistent sympathetic outflow triggers adrenal epinephrine and cortisol secretion, increases hepatic glucose output, and blunts pancreatic beta-cell sensitivity. Through targeted high-velocity, low-amplitude (HVLA) adjustments and gentle mobilization techniques, chiropractic care restores physiologic mechanoreceptive afferent input. This dampens paraspinal nociceptive overdrive, lowers sympathetic tone, and promotes parasympathetic activation (elevating vagal nerve tone) (Haavik & Murphy, 2012). Enhanced parasympathetic activity supports splanchnic circulation, digestive rest, pancreatic perfusion, and homeostatic glycemic control.

2. Eliminating the Biomechanical Barriers to Exercise

Physical exercise is the single most potent non-pharmacological treatment for insulin resistance, yet pain stops patients from engaging.

• Resolving mechanical facet restrictions, sacroiliac hypomobility, and postural compensation allows patients to participate in resistance training and aerobic activity pain-free.
• Restoring pain-free joint excursions enables the recruitment of large muscle motor units necessary to drive GLUT4 translocation and reverse hyperinsulinemia.

3. Restoring Interstitial and Lymphatic Dynamics

Thoracic spinal adjustments, rib cage mobilization, and diaphragmatic retraining directly improve thoracic pump mechanics. This maximizes lymphatic drainage and interstitial clearance, helping remove inflammatory cytokines, cellular debris, and lactic acid from hypoxic muscular beds.

Combining Chiropractic with Non-Surgical Therapies

Optimal resolution of metabolic-musculoskeletal conditions demands a multimodal clinical model. Monotherapy frequently stalls because structural fixes cannot cure metabolic fires, and biochemical strategies struggle against severe mechanical barriers.

• Multimodal Conservative Clinical Strategy
  • Chiropractic Adjustment
    • Restores joint kinematics
    • Dampens CNS sympathetic overdrive
  • Massage Therapy & Myofascial
    • Breaks up AGE cross-links
    • Boosts local nitric oxide
    • Lowers tension
  • Physical Therapy & Rehab Sciences
    • Progressive resistance
    • Triggers GLUT4 muscle uptake
    • Strengthens
  • Functional Wellness & Labs
    • Low-glycemic nutrition
    • Gut barrier restoration
    • Fasting insulin & HOMA-IR

Medical Massage Therapy: Remodeling the Extracellular Matrix

• Fascial Shear and Adhesion Lysis: Connective tissue stiffened by AGEs exhibits restricted fascial glide planes. Deep soft-tissue work, myofascial release, and instrument-assisted soft-tissue mobilization (IASTM) mechanically deform rigid collagen fibers, stimulate fibroblast turnover, and reduce adhesions.
• Endothelial Shear Stress and Nitric Oxide: Rhythmic compression and kneading of ischemic skeletal muscle generate shear stress along vascular beds, enhancing local nitric oxide release and countering insulin-mediated microvascular resistance.
• Systemic Neurochemical Shift: Clinical massage significantly reduces serum cortisol and increases serotonin and dopamine levels, supporting central relaxation and blunting stress-driven gluconeogenesis (Field, 2016).

Physical Therapy and Active Rehabilitation

• Progressive Overload and Muscle Hypertrophy: Prescribing targeted eccentric exercises and progressive resistance loading builds insulin-sensitive type IIa muscle fibers. Muscle is the ultimate metabolic sink, consuming up to 80% of postprandial glucose (Egan & Zierath, 2013).
• Corrective Movement Patterns: Correcting kinetic chain imbalances (e.g., lower crossed syndrome, gluteal amnesia) prevents compensatory strain during training, keeping patients consistently active without injury flare-ups.
• Cardiovascular Zone 2 Base Training: Structured low-intensity steady-state cardiovascular programming enhances mitochondrial density and fatty acid oxidation efficiency in skeletal muscle.

Functional Wellness and Precision Nutrition

• Root-Cause Biomarker Tracking: Collaborating under Dr. Cardenas’s medical oversight, we measure beyond basic fasting glucose—evaluating fasting insulin, HOMA-IR, HbA1c, hs-CRP, Apolipoprotein B (ApoB), and liver enzymes (ALT/AST/GGT).
• Targeted Gut Barrier Repair: Given that endotoxemia drives TLR4-mediated inflammation, we use glutamine, zinc carnosine, polyphenol-dense nutrition, and high-fiber prebiotic regimens (producing short-chain fatty acids like butyrate) to tighten enterocyte junctions (Camilleri, 2019).
• Autophagy-Inducing Lifestyle Rhythms: Time-restricted eating protocols (e.g., 12:12 or 14:10), paired with anti-inflammatory Mediterranean dietary patterns, lower postprandial insulin surges, permitting basal autophagic flux to resume clearing accumulated cellular debris.

Clinical Observations from Dr. Alexander Jimenez, DC, APRN

Across three decades of clinical practice in El Paso, Texas, several key clinical patterns highlight the intersection of metabolic health, insulin dynamics, and musculoskeletal rehabilitation:

1. Normal Weight Does Not Guarantee Metabolic Health: A significant subset of patients presenting with recurring myofascial pain, facet syndrome, or multiple benign lipomas carry a normal BMI yet exhibit marked hyperinsulinemia and high HOMA-IR. Evaluating fasting insulin is essential; fasting glucose alone frequently misses underlying dysfunction.
2. The “Tired and Wired” Autonomic State: Patients with high insulin resistance routinely demonstrate chronic suboccipital tension, restricted mid-thoracic mobility, and elevated resting heart rates. When thoracic adjustments and diaphragmatic breathing exercises restore mobility, heart rate variability (HRV) metrics improve alongside glycemic stability.
3. Pain Reduction Unlocks Glycemic Control: Patients struggling with stubborn HbA1c elevations often see their numbers improve only after resolving their chronic spinal and lower-extremity pain. Restoring pain-free joint articulation allows patients to perform regular brisk walking and postprandial movement, which dramatically improves glucose disposal.
4. Gut-Spine-Metabolism Axis: Patients presenting with spinal myofascial pain alongside chronic bloating, food sensitivities, and metabolic sluggishness experience substantial improvements in back pain and overall mobility when following gut-barrier restoration and anti-inflammatory protocols.

For detailed clinical perspectives, visit Health Coach Clinic and Dr. Alexander Jimenez’s Professional Profile.

Step-by-Step Multidisciplinary Care Pathway

1. Comprehensive Diagnostic Triad:
   • Detailed neuromusculoskeletal, postural, and mobility screening.
   • Advanced laboratory assessment (fasting insulin, HOMA-IR, hs-CRP, metabolic panel, lipid fractionation) under Dr. Cardenas’s medical direction.
   • Evaluation of lifestyle, sleep architecture, and stress physiology.
2. Acute Pain Mitigation and Neuromuscular Reset:
   • HVLA spinal adjustments and joint mobilization to relieve mechanical blockages and dampen sympathetic overdrive.
   • Deep medical massage and myofascial trigger point release to restore blood flow to ischemic muscles.
3. Functional Metabolic Stabilization:
   • Shift to low-glycemic, anti-inflammatory nutrition rich in omega-3 fatty acids, polyphenols, and fiber to reduce metabolic endotoxemia.
   • Application of gut-restorative nutrients (zinc carnosine, L-glutamine).
   • Medical pharmacotherapy coordination through Dr. Cardenas if pharmacologic management (e.g., metformin, GLP-1 RAs) is clinically indicated.
4. Active Rehabilitation and Exercise Progression:
   • Transition to physical therapy: progressive resistance training to upregulate muscle GLUT4 expression.
   • Low-intensity aerobic zone 2 conditioning to drive mitochondrial biogenesis and autophagic clearance.
5. Long-Term Homeostasis and Prevention:
   • Sleep optimization routines and autonomic stress recalibration.
   • Periodic laboratory reassessment and ongoing conservative maintenance care to preserve musculoskeletal mobility and metabolic health.

Conclusion

Insulin resistance is not merely a precursor to diabetes; it is a whole-body pathology that stiffens connective tissue, fuels chronic joint and muscle pain, disrupts autonomic balance, and locks cellular waste clearance pathways. Treating chronic pain while ignoring metabolic dysfunction offers only short-term relief; likewise, prescribing exercise to a patient in debilitating musculoskeletal pain is rarely successful. By combining evidence-based chiropractic adjustments, medical internal medicine oversight, restorative medical massage, targeted physical therapy, and functional wellness, we break the pain–immobility–metabolism cycle. This comprehensive approach restores joint motion, calms the nervous system, reactivates cellular renewal, and helps patients achieve long-term musculoskeletal and metabolic vitality.

References

• Berenbaum, F., Wallace, I. J., Lieberman, D. E., & Felson, D. T. (2017). Modern osteoarthritis: An engine of chronic metabolic inflammation. Nature Reviews Rheumatology, 14(1), 59–65. doi.org/10.1038/nrrheum.2017.198

• Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54(6), 1615–1625. doi.org/10.2337/diabetes.54.6.1615

• Camilleri, M. (2019). Leaky gut: Mechanisms, measurement and clinical implications in humans. Gut, 68(8), 1516–1526. doi.org/10.1136/gutjnl-2019-318427https://doi.org/10.1136/gutjnl-2019-318427

• Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., Waget, A., Delmée, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrières, J., Tanti, J. F., Gibson, G. R., & Burcelin, R. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772. doi.org/10.2337/db06-1491

• Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015). Cellular senescence: At the crossroads of disease and aging. Nature Medicine, 21(12), 1424–1435. doi.org/10.1038/nm.4000

• Chrousos, G. P. (2009). Stress and disorders of the stress system. Nature Reviews Endocrinology, 5(7), 374–381. doi.org/10.1038/nrendo.2009.106

• de Oliveira, R. R., Martins, C. S., & Rocha, C. (2020). Advanced glycation end-products and tendon pathology: A systemic overview of matrix changes and clinical implications. Frontiers in Endocrinology, 11, 584. doi.org/10.3389/fendo.2020.00584

• Egan, B., & Zierath, J. R. (2013). Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metabolism, 17(2), 162–184. doi.org/10.1016/j.cmet.2012.12.012

• Erekat, N. S. (2022). Musculoskeletal complications of diabetes mellitus: A comprehensive review of pathophysiology and therapeutic strategies. World Journal of Diabetes, 13(5), 342–358. doi.org/10.4239/wjd.v13.i5.342

• Field, T. (2016). Massage therapy research review. Complementary Therapies in Clinical Practice, 24, 19–31. doi.org/10.1016/j.ctcp.2016.04.005

• Haavik, H., & Murphy, B. (2012). The role of spinal manipulation in addressing disordered sensorimotor integration and altered motor control. Journal of Electromyography and Kinesiology, 22(5), 768–776. doi.org/10.1016/j.jelekin.2012.02.012

• Jimenez, A. (n.d.). Postural Strain: The Reset Sensation and How to Cope. Health Coach Clinic.

• Jimenez, A. (2020). Glucose Management. Health Coach Clinic.

• Jimenez, A. (2026). Sugar Hangovers: Real Effects and Recovery Strategies. Health Coach Clinic.

• Laplante, M., & Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell, 149(2), 274–293. doi.org/10.1016/j.cell.2012.03.017

• Levine, B., & Kroemer, G. (2019). Biological functions of autophagy genes: A disease perspective. Cell, 176(1–2), 11–42. doi.org/10.1016/j.cell.2018.09.041

• Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007). Cardiovascular actions of insulin. Endocrine Reviews, 28(5), 463–491. doi.org/10.1210/er.2007-0006

• Petersen, M. C., & Shulman, G. I. (2018). Mechanisms of insulin action and insulin resistance. Physiological Reviews, 98(4), 2133–2223. doi.org/10.1152/physrev.00063.2017

• Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. The Spine Journal, 2(5), 357–371. doi.org/10.1016/S1529-9430(02)00400-X

• Richter, E. A., & Hargreaves, M. (2013). Exercise, GLUT4, and skeletal muscle glucose uptake. Physiological Reviews, 93(3), 993–1017. doi.org/10.1152/physrev.00038.2012

SEO tags: lipomas, autophagy, hyperinsulinemia, mTOR, insulin resistance, PPAR gamma, leaky gut, LPS, inflammation, mesenchymal stem cells, senescence, mitochondria, chiropractic care, integrative medicine, functional medicine, El Paso, Dr. Alexander Jimenez, Dr. Maria Guadalupe Cardenas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, stress physiology, vagal tone, sleep optimization, rehabilitation, personal injury care, metabolic health, adipose tissue